Author:
Liu Pengpeng,Li Guangyao,Han Mei,Cheng Xiao,Cui Ying,MD ,Yang Qinglin,MD ,Zhang Chao
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Public Health, Environmental and Occupational Health,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Reference30 articles.
1. Meyer-Rüsenberg B, Loderstädt U, Richard G, et al. Epidemic keratoconjunctivitis: the current situation and recommendations for prevention and treatment. Dtsch Arztebl Int. 2011;108(27):475–80.
2. Ghebremedhin B. Human adenovirus: viral pathogen with increasing importance. Eur J of Microbial Immuno 1(BP). 2014;4(1):26–33.
3. Udeh BL, Schneider JE, Ohsfeldt RL. Cost effectiveness of a point-of-care test for adenoviral conjunctivitis. Am J Med Sci. 2008;336(3):254–64.
4. Tabbara KF, Omar N, Hammouda E, et al. Molecular epidemiology of adenoviral keratoconjunctivitis in Saudi Arabia. Mol Vis. 2010;16:2132–6.
5. Jhanji V, Chan TC, Li EY, et al. Adenoviral keratoconjunctivitis. Surv Ophthalmol. 2015;60:435–43.